Literature DB >> 208229

Deviated formation of intestinal glycocalyx in human stomach cancer cells. Another type of signet ring cell.

S Tokumitsu, K Tokumitsu, H Nomura, T Takeuchi.   

Abstract

The process of glycocalyx formation by the trilaminar membrane was investigated at the subcellular level by use of cultivated cancer cells derived from a human stomach adenocarcinoma. Glycocalyx was apparently synthesized on the characteristic trilaminar membrane of Golgi-derived vesicles which gave rise to cytoplasmic vacuoles which, in turn, fused to form an intracytoplasmic cyst. Characteristic microvilli similar to those of intestinal epithelium extended from the membrane lining the intracytoplasmic cyst. These ultrastructural features agree with earlier histochemical findings in suggesting intestinal metaplasia in the origin of the gastric tumor. The morphologic features of the cancer cells clearly indicated that glycoprotein is first synthesized in the Golgi complex and fully formed mucoprotein then emerges as membrane-bound glycocalyx in the vesicles budding from the Golgi stacks. The glycocalyx layer is an integral part of the external leaflet of the characteristic trilaminar membrane. Abundant deposits of glycocalyx in the intracytoplasmic cyst constituted the ultrastructural basis for a distinctive type of signet ring cell that differed from mucous signet ring cells derived from goblet cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 208229     DOI: 10.1007/bf02888996

Source DB:  PubMed          Journal:  Virchows Arch B Cell Pathol


  2 in total

1.  Cell proliferation and differentiation in intramucosal and advanced signet ring cell carcinomas of the human stomach.

Authors:  H Sugihara; T Hattori; M Fukuda; S Fujita
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

2.  Cellular differentiation and histogenesis of rat glandular stomach cancers.

Authors:  M Tatematsu; T Katsuyama; C Furihata; S Fukushima; T Shirai; T Kato; N Ito
Journal:  Jpn J Cancer Res       Date:  1990-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.